Image via GeekWire
Wednesday, September 3, 2025
AI Spots Strokes Faster Than Doctors
We're watching AI literally save lives now: an NHS stroke scanner powered by machine learning is tripling recovery rates and cutting treatment delays by a full hour (wild stuff). Meanwhile, the FDA is making a bold move away from animal testing toward AI-powered drug discovery, which could reshape how we develop medicine entirely. On the business side, Meta's $14B Scale AI deal is showing cracks amid talent exodus and quality concerns (yikes), while Google Gemini is leveling up image generation with character consistency, and Alibaba is surging on triple-digit AI revenue expansion and custom chip development. The question haunting everyone: if AI can outperform doctors and replace animal testing, what jobs actually survive the next five years?
Image via GeekWire
Top Stories
AI-powered stroke detection is now deployed across all English NHS stroke centres, reducing treatment delays by an hour and tripling recovery rates to near 50% of patients achieving functional independence, showcasing transformative potential in emergency healthcare.
The FDA is modernizing drug discovery by allowing alternatives to animal testing through validated computational and in vitro methods, though industry experts stress these tools must complement rather than entirely replace animal models for complex safety assessments.
Meta's $14B Scale AI deal is unraveling with executive departures, internal quality disputes, and shifting partnerships to competitors, signaling deeper organizational problems in its AI superintelligence push despite massive investment and talent recruitment.
Google's updated Gemini image generation model enables character consistency, precise editing, and creative image blending; the company shares best practices for prompt engineering to maximize creative control and output quality.
Alibaba's cloud unit and AI infrastructure investments are driving investor confidence, with accelerating cloud growth and emerging custom chip development positioning the company to capitalize on AI monetization similar to Microsoft and Google.
Keep Reading
Industry Voices
Shengjia Zhao
Chief Scientist at Meta Superintelligence Labs
Get early signals on Meta's superintelligence research direction from someone building the actual systems, not just talking about them.
Yann LeCun
Chief AI Scientist at Meta
Unfiltered takes on why AGI doomers are wrong and what self-supervised learning will actually unlock next.
Olivier Godement
Head of Product, API at OpenAI
See what API features OpenAI is shipping before they hit your product roadmap—he decides what developers get to build with.
Katie Hainsey
Head of AI/ML at JPMorgan Chase
Learn how a $4 trillion bank actually deploys AI at scale while navigating regulation, risk, and legacy systems.
Ekin Dogus Cubuk
Co-founder at Periodic Labs
Track cutting-edge ideas in automated machine learning from a Google Brain alum now betting his own startup on what's next.
Enjoyed this issue?
Get daily AI intel delivered to your inbox. No fluff, just the stories that matter.